Clinical Trials Directory

Trials / Unknown

UnknownNCT03524950

Effect of Dexmedetomidine on Stress Study of Pituitrin in Laparoscopic Hysteromyoma Surgery

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Beijing Anzhen Hospital · Academic / Other
Sex
Female
Age
40 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study is about the effect of dexmedetomidine to the stress of pituitrin in laparoscopic hysteromyoma surgery. It is well known that pituitrin has been widespread used in the laparoscopic hysteromyoma surgery. Pituitrin includes oxytocin and vasopressin. Vasopressin increase body stress reaction through hypothalamic pituitary adrenal(HPA) axis. The HPA axis has has main role to the body stress reaction. Dexmedetomidine can inhibit the stress responses mediated by the sympathetic nervous system. Therefore,the effect of dexmedetomidine to the stress of pituitrin in laparoscopic hysteromyoma surgery is worth to be studied.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineNinety patients will be assigned to three groups. Group A add saline in general anesthesia laparoscopic hysteromyoma surgery. Group B add dexmedetomidine 1μg/Kg10minutes as loading dose, followed by 0.7μg/Kg/h for maintenance.Group C add dexmedetomidine 0.7μg/Kg10minutes as loading dose, followed by 0.5μg/Kg/h for maintenance.

Timeline

Start date
2018-06-01
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2018-05-15
Last updated
2018-05-15

Source: ClinicalTrials.gov record NCT03524950. Inclusion in this directory is not an endorsement.